- Home
- BDJ vs OPK Comparison
BDJ vs OPK Comparison
Compare BDJ & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDJ
- OPK
- Stock Information
- Founded
- BDJ 2005
- OPK 2007
- Country
- BDJ United States
- OPK United States
- Employees
- BDJ N/A
- OPK N/A
- Industry
- BDJ Finance Companies
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- BDJ Finance
- OPK Health Care
- Exchange
- BDJ Nasdaq
- OPK Nasdaq
- Market Cap
- BDJ 1.5B
- OPK 1.3B
- IPO Year
- BDJ N/A
- OPK 1995
- Fundamental
- Price
- BDJ $8.63
- OPK $1.70
- Analyst Decision
- BDJ
- OPK Strong Buy
- Analyst Count
- BDJ 0
- OPK 3
- Target Price
- BDJ N/A
- OPK $2.75
- AVG Volume (30 Days)
- BDJ 561.6K
- OPK 7.9M
- Earning Date
- BDJ 01-01-0001
- OPK 05-06-2025
- Dividend Yield
- BDJ 8.85%
- OPK N/A
- EPS Growth
- BDJ N/A
- OPK N/A
- EPS
- BDJ N/A
- OPK N/A
- Revenue
- BDJ N/A
- OPK $713,142,000.00
- Revenue This Year
- BDJ N/A
- OPK N/A
- Revenue Next Year
- BDJ N/A
- OPK $6.25
- P/E Ratio
- BDJ N/A
- OPK N/A
- Revenue Growth
- BDJ N/A
- OPK N/A
- 52 Week Low
- BDJ $6.91
- OPK $1.15
- 52 Week High
- BDJ $8.66
- OPK $2.04
- Technical
- Relative Strength Index (RSI)
- BDJ 45.25
- OPK 44.12
- Support Level
- BDJ $8.55
- OPK $1.75
- Resistance Level
- BDJ $8.78
- OPK $1.80
- Average True Range (ATR)
- BDJ 0.11
- OPK 0.07
- MACD
- BDJ 0.00
- OPK -0.02
- Stochastic Oscillator
- BDJ 46.43
- OPK 7.41
About BDJ Blackrock Enhanced Equity Dividend Trust
BlackRock Enhanced Equity Dividend Trust is a United States closed-end management investment company. Its investment objective is to seek current income and current gains, with a secondary objective of long-term capital appreciation.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.